EMR vs ZBIO · P/E 34, rev $4.86B vs rev $10.0M
Emerson Electric Company (EMR) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
EMR currently screens at market cap $83.45B and trailing P/E 34.5. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the EMR and ZBIO stock pages for the full models.
Not investment advice.